Clinical Trial

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia. Schizophrenia patients with depressive symptoms will be exposed to rTMS to improve their symptoms.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-01.
Status change: Not Yet Recruiting → Recruiting 2025-12-12
Trial Details
NCT Number NCT07060066
Lead Sponsor The University of Texas Health Science Center, Houston
Collaborators: National Institute of Mental Health (NIMH)
Conditions Schizophrenia and Related Disorders
Enrollment 120 participants
Start Date 2025-10-23
Primary Completion 2030-06-01 (estimated)
Study Completion 2030-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-05